Scientists have discovered a substance that may become an oral treatment for diabetes and its complications. Results indicate that the new yeast-derived treatment acts similarly to insulin in the rats, lowering the level of glucose, and of LDL-cholesterol, (the “bad” cholesterol), and raising the level of HDL-cholesterol (the “good” cholesterol).